跳至主要内容
临床试验/NCT04369443
NCT04369443已完成不适用

Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
Volume of allogeneic blood transfusion

研究概览

简要总结

The application of acute Normovolemic Hemodilution in cardiac surgery can effectively reduce perioperative blood transfusion, reduce postoperative complications and mortality, and is a low-cost, operable and effective blood protection measure.For the application of Acute Normovolemic Hemodilution in heart surgery, we still face an urgent problem: to what extent can Acute Normovolemic Hemodilution achieve better "blood saving effect", that is, whether a large number of Acute Normovolemic Hemodilution can reduce perioperative blood transfusion to a greater extent

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1)18-75years old;(2)elective cardiac surgery under cardiopulmonary bypass; (3)Preoperative hemoglobin (Hb) ≥ 12g/dl; (4) Transfusion Risk Understanding Scoring Tool (TRUST) ≥ 2 (possibility of blood transfusion ≥40%).

排除标准

  • (1)congenital heart disease、Cardiac tumor、aortic dissection、heart transplantation(2)Low body weight(<50 kg);(3)preoperative shock;(4)myocardial infarction within 3 months before surgery;(5)ischemic heart disease;Left main coronary artery stenosis >70%;Severe aortic stenosis (area < 0.7cm2);Severe changes in left ventricular function (ejection fraction <30%, requiring vasoactive agents to assist circulation);(6)severe carotid artery stenosis (>70% or with symptoms);(7) kidney failure (blood creatinine level >442 mmol/L) or dialysis treatment;(8) serum albumin level (ALB) is less than 25 g/L.(9) international standardized ratio (INR) >1.5 or platelet count <100 103/mm3;(10)Inherited/acquired coagulation function defect;(11)contagious or infectious diseases;(12) patient or family members refused to participate in research;(13)refused to infusion of autologous blood or allogeneic blood products

结局指标

主要结局

Volume of allogeneic blood transfusion

时间窗: Through study completion,about 8 months

The mean volume of allogeneic blood transfusion

次要结局

  • Rate of postoperative cardiac complications(Through study completion,about 8 months)
  • Rate of postoperative renal complication(Through study completion,about 8 months)
  • Rate of postoperative pulmonary complications(Through study completion,about 8 months)
  • Other severe complication(Through study completion,about 8 months)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验